Arformoterol Tartrate Inhalation
Active substance: arformoterol
SOLUTION · ARFORMOTEROL TARTRATE 15 ug/2mL
United StatesActive
Marketing holder: Slate Run Pharmaceuticals
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- ARFORMOTEROL TARTRATE · 15 ug/2mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208d-171f-74ea-b767-f5495f94ddbe,01a1208d-323c-7d0f-9bff-d93207904dd8,01a1208d-575d-76f8-826d-7a2f28d3de26,01a1208f-b063-717a-b466-a523341cc282,01a12090-b95f-72f4-b60f-343f6bf8da17;count=15 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 70436-151
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- RESPIRATORY (INHALATION)
Sources
- product · openFDA NDC · 70436-151 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 70436-151 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 70436-151 · Verified 2026-10-09 · open in source